LiverMetSurvey

Progress in the treatment of colorectal liver metastases has led to new therapeutic strategies in the last few years.

The LiverMetSurvey program gathers data from patients operated for colorectal liver metastasis, whether resected or not. The data includes patient history, treatments (chemotherapy, surgery, combined ablation) and operated patients’ outcomes.

300 centers in 55 countries actively participate in this registry. They included data from more than 34,000 patients and more than 40,000 operations.

LiverMetSurvey is the first international registry of patients operated on for liver metastases from colorectal cancer. The database constitutes a valuable tool for improving care pathways for patients with colorectal liver metastases.

The program includes an international scientific committee made up of surgeons and oncologists.

The A.R.CA.D LiverMetSurvey program is opened to all centers across the world, whether private or public. Investigators are requested to include all their operated patients consecutively and to provide their follow-up on a long-term basis.